Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments.
Lennart KesterDanielle SeinstraAnnelot G J van RossumClaire VenninMarlous HoogstraatDaphne L van der VeldenMark OpdamErik D van WerkhovenKerstin HahnIris NederlofEster H LipsIngrid A M MandjesA Elise van Leeuwen-StokSander CanisiusHarm D R van TinterenAlex L T ImholzJohanneke E A PortieljeMonique E M M BosSandra D BakkerEmiel J T RutgersHugo M HorlingsJelle WesselingEmile E VoestLodewyk F A WesselsMarleen KokHendrika M OosterkampAlexander van OudenaardenSabine C LinnJacco van RheenenPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
From our study, we conclude that differential survival and therapy benefit of patients with breast cancer are characterized by distinct microenvironments that include specific populations of immune and epithelial cells.
Keyphrases